|
Invited Speakers:
|
|
Adrian Bot, MD, Ph.D., Chief Scientific Officer, Kite Pharma Inc. Maurizio Chiriva-Internati, DBSc, Ph.D., Director of Basic/Translational Research Program, Division of Hematology & Oncology, Southwest Cancer Research & Treatment Center at University Medical Center,Texas Tech University of Health Sciences Center School of Medicine
Andrew Cornforth, Ph.D., Cancer Stem Cell Program Manager, California Stem Cell, Inc.
Soldano Ferrone, MD, Ph.D., Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School Kenneth Geles, Ph.D., Senior Principal Scientist, Oncology Research Unit, Pfizer Inc. Richard C. Koya, MD, Ph.D., Assistant Professor, Department of Surgery, Surgical Oncology, Member, JCCC Tumor Immunology Program, University of California, Los Angeles Douglas G. McNeel, MD Ph.D., Associate Professor of Medicine, University of Wisconsin Masoud H. Manjili, DVM, Ph.D., Associate Professor, Department of Microbiology & Immunology,Virginia Commonwealth University School of Medicine William Matsui, MD, Associate Professor of Oncology, Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Richard A. Morgan, Ph.D., Staff Scientist, Surgery Branch, Tumor Immunology Section, National Cancer Institute Nicholas P. Restifo, MD, Principal Investigator, Center for Cancer Research, National Cancer Institute David M. Spencer, Ph.D., Chief Scientific Officer, Bellicum Pharmaceuticals, Inc. Robert Tressler, Ph.D., Vice President of Research & Development, Cellerant Therapeutics, Inc. Albert J. Wong, MD, Professor, Director, Brain Tumor Research Laboratories, Deptartment of Neurosurgery/Cancer Biology Program, Stanford University Medical Center Lili Yang, Ph.D., Lead Scientist & Project Manager, Engineering Immunity Program, Laboratory of David Baltimore, Division of Biology, California Institute of Technology
|
|